Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
101.3 INR | -0.64% |
|
-2.50% | -18.70% |
06-20 | Crisil Keeps BBB+ Rating on Bliss GVS Pharma's Bank Loans; Outlook Stable | MT |
05-02 | Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-18.70% | 128M | |
+20.76% | 43.59B | |
+28.00% | 22.54B | |
+20.14% | 15.73B | |
+18.82% | 14.33B | |
+55.83% | 12.75B | |
-0.05% | 6.79B | |
-12.70% | 6.48B | |
-8.87% | 5.73B | |
+15.72% | 5.67B |
- Stock Market
- Equities
- BLISSGVS Stock
- News Bliss GVS Pharma Limited
- Bliss GVS Pharma Gets Establishment Inspection Report from US FDA for Palghar, India Unit